BONE SCANS IN THE MANAGEMENT OF METASTATIC CASTRATE-RESISTANT PROSTATE CANCER: SURVEY OF PATTERNS OF PRACTICE IN CANADIAN RADIATION ONCOLOGISTS, MEDICAL ONCOLOGISTS AND UROLOGISTS

被引：0
|
作者：
Meem, Mahbuba [1 ]
Zukotynski, Katherine [2 ]
Raman, Srinivas [1 ]
Emmenegger, Urban [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] McMaster Univ, Hamilton, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
189
引用
收藏
页码：S79 / S80
页数：2
相关论文
共 50 条
  • [31] How multidisciplinary teams (MDTs) work in practice in the management of advanced prostate cancer: A survey of oncologists and urologists in the UK
    Payne, Heather A.
    Bahl, Amit
    Kockelbergh, Roger
    Troup, Janis
    JOURNAL OF CLINICAL UROLOGY, 2011, 4 (02) : 68 - 77
  • [32] Delivering Optimal Care for Metastatic Prostate Cancer: A Strengthening Alliance Between Urologists and Medical Oncologists
    Briganti, Alberto
    De Santis, Maria
    Giannarini, Gianluca
    Sweeney, Christopher J.
    EUROPEAN UROLOGY FOCUS, 2016, 2 (05): : 463 - 464
  • [33] Multiparametric MRI for prostate cancer: a national survey of patterns of practice among radiation oncologists in Spain
    Counago, F.
    Sancho, G.
    Gomez-Iturriaga, A.
    Henriquez, I.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (11): : 1484 - 1491
  • [34] Bisphosphonate use for the management of breast cancer patients with bone metastases: A survey of Canadian Medical Oncologists
    Sunil Verma
    Danielle Kerr-Cresswell
    George Dranitsaris
    Flay Charbonneau
    Maureen Trudeau
    Geetha Yogendran
    Anne-Marie Cesta
    Mark Clemons
    Supportive Care in Cancer, 2004, 12 : 852 - 858
  • [35] Bisphosphonate use for the management of breast cancer patients with bone metastases: A survey of Canadian Medical Oncologists
    Verma, S
    Kerr-Cresswell, D
    Dranitsaris, G
    Charbonneau, F
    Trudeau, M
    Yogendran, G
    Cesta, AM
    Clemons, M
    SUPPORTIVE CARE IN CANCER, 2004, 12 (12) : 852 - 858
  • [36] A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer
    Kim, Simon P.
    Karnes, R. Jeffrey
    Nguyen, Paul L.
    Ziegenfuss, Jeanette Y.
    Thompson, R. Houston
    Han, Leona C.
    Shah, Nilay D.
    Smaldone, Marc C.
    Gross, Cary P.
    Frank, Igor
    Weight, Christopher J.
    Beebe, Timothy J.
    Tilburt, Jon C.
    BJU INTERNATIONAL, 2014, 113 (5B) : E106 - E111
  • [37] A Population-based Study Comparing Outcomes for Patients With Metastatic Castrate Resistant Prostate Cancer Treated by Urologists or Medical Oncologists With First Line Abiraterone Acetate or Enzalutamide
    Woon, Dixon T. S.
    Finelli, Antonio
    Cheung, Douglas C.
    Martin, Lisa J.
    Alibhai, Shabbir
    Wallis, Christopher J. D.
    Diong, Christina
    Saskin, Refik
    Kulkarni, Girish
    Fleshner, Neil
    UROLOGY, 2021, 153 : 147 - 154
  • [38] A Population-based Study Comparing Outcomes for Patients With Metastatic Castrate Resistant Prostate Cancer Treated by Urologists or Medical Oncologists With First Line Abiraterone Acetate or Enzalutamide
    Tsao, Phoebe A.
    Caram, Megan E. V.
    UROLOGY, 2021, 153 : 154 - 154
  • [39] Use of bone modifying agents for metastatic castrate-resistant prostate cancer.
    Mitchell, Aaron Philip
    Meza, Akriti Mishra
    Farooki, Azeez
    Panageas, Katherine
    Bach, Peter B.
    Lipitz-Snyderman, Allison
    Morris, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [40] Comparison of outcomes for patients with metastatic castrate resistant prostate cancer treated by urologists or medical oncologists with first line abiraterone acetate or enzalutamide: a population-based study
    Woon, D.
    Finelli, A.
    Wallis, C. J. D.
    Cheung, D.
    Martin, L.
    Saskin, R.
    Fleshner, N.
    BJU INTERNATIONAL, 2020, 125 : 56 - 57
12345